Close Menu

NEW YORK (360Dx) – Ceres Nanosciences said today that with Tasso, George Mason University, and the United States Army Medical Research Institute of Infectious Diseases, it has received $4.25 million from the US Department of Defense's Defense Threat Reduction Agency (DTRA) to develop a platform for surveillance of infectious disease outbreaks.

The award is part of a larger, multi-year $11.7 million program funded by the DTRA through which Ceres will work to integrate its Nanotrap enrichment technology with Tasso's HemoLink blood sampling device.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.